A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Isoray, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 12,267,432 shares of ISR stock, worth $8.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,267,432
Holding current value
$8.46 Million
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
N/A
12,267,432 New
12,267,432 $8.46 Million
Q2 2023

Aug 14, 2023

BUY
$0.0 - $0.69 $0 - $115,077
166,779 New
166,779 $115,000
Q4 2022

Feb 14, 2023

BUY
$0.24 - $0.4 $67,135 - $111,892
279,730 Added 1079.83%
305,635 $73,000
Q3 2022

Nov 14, 2022

SELL
$0.22 - $0.43 $3,325 - $6,499
-15,115 Reduced 36.85%
25,905 $6,000
Q2 2022

Aug 15, 2022

SELL
$0.26 - $0.37 $22,339 - $31,790
-85,920 Reduced 67.69%
41,020 $13,000
Q1 2022

May 16, 2022

BUY
$0.31 - $0.41 $36,004 - $47,618
116,142 Added 1075.59%
126,940 $46,000
Q3 2021

Nov 15, 2021

SELL
$0.58 - $0.79 $23,517 - $32,032
-40,548 Reduced 78.97%
10,798 $7,000
Q2 2021

Aug 16, 2021

SELL
$0.75 - $1.15 $53,241 - $81,636
-70,988 Reduced 58.03%
51,346 $41,000
Q1 2021

May 17, 2021

BUY
$0.53 - $2.47 $14,533 - $67,729
27,421 Added 28.89%
122,334 $134,000
Q4 2020

Feb 16, 2021

BUY
$0.36 - $0.58 $12,796 - $20,617
35,547 Added 59.88%
94,913 $43,000
Q3 2020

Nov 16, 2020

SELL
$0.54 - $0.78 $8,681 - $12,540
-16,077 Reduced 21.31%
59,366 $35,000
Q2 2020

Aug 14, 2020

BUY
$0.47 - $0.86 $24,554 - $44,929
52,244 Added 225.2%
75,443 $42,000
Q1 2020

May 15, 2020

SELL
$0.53 - $0.99 $7,159 - $13,373
-13,509 Reduced 36.8%
23,199 $12,000
Q4 2019

Feb 14, 2020

SELL
$0.3 - $0.69 $8,113 - $18,661
-27,046 Reduced 42.42%
36,708 $23,000
Q3 2019

Nov 14, 2019

BUY
$0.31 - $0.42 $7,671 - $10,393
24,747 Added 63.44%
63,754 $20,000
Q2 2019

Aug 14, 2019

SELL
$0.37 - $0.47 $2,432 - $3,090
-6,575 Reduced 14.42%
39,007 $16,000
Q1 2019

May 15, 2019

BUY
$0.32 - $0.46 $7,188 - $10,333
22,464 Added 97.17%
45,582 $0
Q4 2018

Feb 14, 2019

SELL
$0.27 - $0.52 $30,540 - $58,819
-113,114 Reduced 83.03%
23,118 $6,000
Q1 2018

May 11, 2018

BUY
$0.4 - $0.49 $16,784 - $20,560
41,960 Added 44.51%
136,232 $57,000
Q4 2017

Feb 09, 2018

BUY
$0.39 - $0.55 $25,106 - $35,406
64,375 Added 215.32%
94,272 $38,000
Q3 2017

Nov 09, 2017

BUY
$0.51 - $0.6 $15,247 - $17,938
29,897
29,897 $15,000

Others Institutions Holding ISR

About Isoray, Inc.


  • Ticker ISR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 142,112,992
  • Market Cap $98.1M
  • Description
  • Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...
More about ISR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.